Log in to save to my catalogue

Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate...

Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5522830

Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer

About this item

Full title

Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer

Publisher

New Zealand: Dove Medical Press Limited

Journal title

OncoTargets and therapy, 2017-01, Vol.10, p.3531-3543

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Prostate cancer is a complex disease that can be relatively harmless or extremely aggressive. Although androgen-deprivation therapy is a commonly used treatment for men with prostate cancer, the adverse effects can be detrimental to patient health and quality of life. Therefore, identifying new target genes for tumor growth will enable the developm...

Alternative Titles

Full title

Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5522830

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5522830

Other Identifiers

ISSN

1178-6930

E-ISSN

1178-6930

DOI

10.2147/OTT.S136491

How to access this item